A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil

PURPOSE: We studied the safety, tolerability, virologic, and immunologic effects of mycophenolate mofetil (MMF) added to a stable antiretroviral therapy (ART) in the setting of low-level viremia. METHODS: MMF 500 mg BID or placebo was given to patients thought to be adherent on stable ART with plasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Rupinderjeet, Bedimo, Roger, Kvanli, Mary Beth, Turner, Diana, Shaw, Leslie, Margolis, David
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513387/
https://www.ncbi.nlm.nih.gov/pubmed/16729890
http://dx.doi.org/10.1186/1742-6405-3-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513387/
https://www.ncbi.nlm.nih.gov/pubmed/16729890
http://dx.doi.org/10.1186/1742-6405-3-16

Ejemplares similares